LR

Lipsa Rani Mohanty

Active Director Director DIN 10901892
DIN 10901892 First appointment Jan 2025 Primary industry Consumer Products
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Lipsa Rani Mohanty

Data last updated:

Lipsa Rani Mohanty is a Director at Reprex Lifesciences Private Limited (since 2025). The company operates in Consumer Products.

DIN 10901892
Primary Designation Director
Industry Consumer Products
First Appointment 09 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Reprex Lifesciences Private Limited U47720TS2025PTC192757
Director09 Jan 20252025Active

Board colleagues of Lipsa Rani Mohanty

NameDINCompanyDesignation
Rakesh Kumar Pradhan10901893Reprex Lifesciences Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Reprex Lifesciences Private Limited
Premium access

Shareholding and investment profile for Lipsa Rani Mohanty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lipsa Rani Mohanty

Lipsa Rani Mohanty currently holds 1 directorship: Reprex Lifesciences Private Limited (Director, since 09 Jan 2025).

Lipsa Rani Mohanty was first appointed on 09 Jan 2025 as Director at Reprex Lifesciences Private Limited.

The current boards of Lipsa Rani Mohanty's companies include Rakesh Kumar Pradhan (Reprex Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available